Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-23

FDA Approved: LUBIPROSTONE — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved the original application for lubiprostone from Zydus Pharmaceuticals USA Inc., establishing a generic version of Lubiprostone. The approval covers …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUBIPROSTONE (lubiprostone)

Snippet

ORIG AP for LUBIPROSTONE (LUBIPROSTONE)